Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth

/PRNewswire/ -- The amyotrophic lateral sclerosis treatment market is expected to grow by USD 663.7 million from 2023 to 2028. In addition, the momentum of the...

Related Keywords

United States ,United Kingdom ,American ,America ,Jesse Maida ,Lou Gehrig ,Biogen Inc ,Sun Pharmaceutical Industries Ltd ,Otsuka Holdings Co ,Cytokinetics Inc ,Apotex Inc ,Technavio Research ,Medindia Health ,Dr Reddys Laboratories Ltd ,Alkem Laboratories Ltd ,Aquestive Therapeutics Inc ,Denali Therapeutics Inc ,Company Landscape ,Italfarmaco Holding ,Mitsubishi Chemical Group Corp ,Company Profile ,Revalesio Corp ,Company Analysis ,Ionis Pharmaceuticals Inc ,Eledon Pharmaceuticals Inc ,Brainstorm Cell Therapeutics Inc ,Pfizer ,Distribution Channel ,North America ,Sangamo Therapeutics ,North American ,Otsuka Holdings ,Therapeutics Inc ,Lateral Sclerosis Treatment Market ,Technavio ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Market Research Reports ,